Profil
David Westberg is currently the Chief Executive Officer & Managing Director at Nanexa AB since 2015.
He is also a Director at W & W Management & Design AB and an Independent Director at Lipigon Pharmaceuticals AB since 2023.
Previously, he worked as the Head-Product Development Department at Pharmacia AB, a Project Manager at Orexo AB, and a Manager-Project & Operations at LIDDS AB. Mr. Westberg graduated from the Royal Institute of Technology.
Aktiva positioner av David Westberg
| Företag | Position | Start |
|---|---|---|
| NANEXA AB | Verkställande Direktör | 2015-04-01 |
| LIPIGON PHARMACEUTICALS AB | Direktör/Styrelseledamot | 2023-01-01 |
W & W Management & Design AB | Direktör/Styrelseledamot | - |
Tidigare kända positioner av David Westberg
| Företag | Position | Slut |
|---|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Företagsledare/Principal | - |
| OREXO AB | Företagsledare/Principal | - |
| LIDDS AB | Verksamhetschef | - |
David Westbergs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Nanexa AB
Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
W & W Management & Design AB | |
Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
















